112249 ⎘
Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from viruses positive strand RNA viruses
Method of detecting antibodies against JEV or ZIKV using recombinant baculoviruses expressing prM/e
#2Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#3Self-inactivating rabies virus vector encoding a nucleoprotein and degron
#4RECOMBINANT BACULOVIRUSES AND THEIR USES IN DETECTING ARTHROPOD-BORNE VIRUS
#5Materials and methods for producing improved lentiviral vector particles
#6Packaging cell for making a pseudotyped lentivirus
#7Recombinant baculoviruses and their uses in detecting arthropod-borne virus
#8Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#9Multigenome retroviral vector preparations and methods and systems for producing and using same
#10Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#11Methods of delivering a pseudotyped lentivirus
#12Materials and methods for producing improved lentiviral vector particles
#13Multigenome retroviral vector preparations and methods and systems for producing and using same
#14Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#15Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#16Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#17Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#18Method of stimulating an immune response using a pseudotyped lentivirus
#19Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein
#20Materials and methods for producing improved lentiviral vector particles
#21Targeting pseudotyped retroviral vectors
#22Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#23Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
#24Targeted gene delivery to dendritic cells
#25ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DISEASES
#26CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES
#27Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#28Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
#29Targeting pseudotyped retroviral vectors
#30Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#31Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#32Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression
#33GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
#34Novel sequences encoding hepatitis C virus glycoproteins
#35Targeting Pseudotyped Retroviral Vectors
#36Targeted gene delivery for dendritic cell vaccination
#37Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#38Infectious pestivirus pseudo-particles containing functional Erns, E1, E2 envelope proteins
#39Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
#40Sequences encoding hepatitis C virus glycoproteins
#41Cytoplasmic inhibition of gene expression
#42Pseudotyped viruses and methods for their use